Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
3.640
+0.160 (4.60%)
At close: Jun 11, 2026, 4:00 PM EDT
3.630
-0.010 (-0.27%)
After-hours: Jun 11, 2026, 7:02 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $79.41 million as of June 11, 2026. Its market cap has decreased by -64.15% in one year.
Market Cap
79.41M
Enterprise Value
-11.45M
1-Year Change
-64.15%
Ranking
Category
Stock Price
$3.64
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $79.41M, a decrease of -76.79%. That is a compound annual growth rate of -66.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 79.41M | -72.21% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MindWalk Holdings | 79.96M |
| Champions Oncology | 79.43M |
| LeonaBio | 79.19M |
| Anixa Biosciences | 78.79M |
| Rani Therapeutics Holdings | 78.15M |
| OKYO Pharma | 77.67M |
| Heron Therapeutics | 77.30M |
| MAIA Biotechnology | 77.22M |